TRIVENI
Amagma, Inc.
Application Filed: 2023-02-24
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 97810745 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Christina M. Licursi |
| Attorney Docket Number | M16022000000 |
Timeline
| 2023-02-24 | Application Filed |
| 2023-03-15 | Location: NEW APPLICATION PROCESSING |
| 2023-03-15 | Status: Live/Pending |
| 2023-03-15 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Amagma, Inc. |
| Address | 100 Beaver Street, Suite 307 Waltham DE 02453 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
 Application | 2023-02-24 | |
| Drawing | 2023-02-24 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical, therapeutic and biopharmaceutical agents; pharmaceutical, therapeutic and biopharmaceutical preparations and substances; biological preparations, namely, antibodies; research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; drug development and discovery; research and analysis services using machine learning analytics relating to drug development; scientific research, pharmaceutical research, medical research, technical consultation, and product development for others in the field of biotechnology and development of pharmaceutical, therapeutic, and biopharmaceutical preparations and agents; research services in the fields of genomic analysis; genomic analysis and sequencing services for scientific and research purposes; medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; DNA analysis and sequencing services for scientific and research purposes; research, development and consultancy in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; platform as a service (PaaS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, metatranscriptomics, and microbiomics; software as a service (SaaS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, metatranscriptomics |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-03-15 | 1 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2023-11-25 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2023-11-30 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2023-11-30 | 4 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2023-11-30 | 5 GNRN O:Outgoing Correspondence |
| APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | 2024-01-05 | 6 XELR I:Incoming Correspondence |
| APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | 2024-01-05 | 7 XELG O:Outgoing Correspondence |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2024-01-17 | 8 ASGN I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2024-05-29 | 9 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2024-05-29 | 10 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2024-05-29 | 11 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2024-06-04 | 12 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2024-06-04 | 13 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2024-06-04 | 14 GNFN O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2024-07-08 | 15 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2024-07-08 | 16 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2024-07-08 | 17 GNRN O:Outgoing Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 